688553 汇宇制药
2026/03 - 三个月
人民币(K¥)
2025/12
人民币(K¥)
2024/12
人民币(K¥)
2023/12
人民币(K¥)
2022/12
人民币(K¥)
经营活动产生之现金流量净额20,16790,513242,95666,933194,060
投资活动产生之现金流量净额(45,153)130,789270,457233,348(181,034)
筹资活动产生之现金流量净额84,72899,949(86,299)122,298(99,990)
汇率变动对现金及现金等价物的影响(1,818)(726)671,641(161)
现金及现金等价物净增加/(减少)57,924320,525427,180424,219(87,125)
期初现金及现金等价物余额2,377,7692,057,2441,630,0641,205,8451,292,970
期末现金及现金等价物余额2,435,6932,377,7692,057,2441,630,0641,205,845